Our breath tells the secrets hidden in our bodies.

Breathe BioMedical is identifying composite biomarkers for routine early disease screening.

Our breath is full of chemicals called Volatile Organic Compounds (VOCs) which are produced by metabolic processes in our bodies. These compounds can reveal a great deal about the clinical state of an individual’s health, environmental exposure, and about metabolic changes.   

Breath analysis allows for timely screening which benefits practitioners in identifying health issues early, which will lead to saving healthcare resources, and more importantly, saving lives. Breathe BioMedical’s technology is being developed to screen for biomarkers of cancer, neurologic and respiratory diseases, often long before symptoms appear. 

Our platform combines three advanced technologies to sample, digitize and analyze breath to screen for disease. 



Just breathe and we’ll collect a sample ready for the lab.


Our advanced infrared spectrometer translates samples into reliable data sets.


Our machine-learning algorithms unpack the vast and complex data at the molecular level for biomarker identification.